Levosert

Levonorgestrel, the active ingredient in Levosert, is a synthetic progestogen presented as a 52 mg intrauterine system for intrauterine use. It provides long‑acting reversible contraception for women of reproductive age, preventing pregnancy for up to three years.

GNH USA supplies Levosert as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved products to a global network of healthcare providers. Levosert is shipped in compliance with international customs and packaging regulations, ensuring product integrity during transit.

Levosert, a levonorgestrel‑releasing intrauterine system, is used within the hormonal contraceptive pathway for preventing unintended pregnancy.

- Long‑acting reversible contraception (up to 3 years): Provides continuous birth control for up to three years. - Prevention of pregnancy: Offers a reliable, progestogen‑only method for women seeking contraception. - Family planning: Enables women to plan pregnancies with a reversible, low‑maintenance option.

Levosert may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Irregular bleeding or spotting during the first months. - Reduced menstrual blood loss or amenorrhea after continued use. - Pelvic or abdominal discomfort. - Headache.

Serious or Rare Side Effects: - Perforation of the uterine wall during insertion. - Expulsion of the device. - Pelvic inflammatory disease. - Allergic reaction to the device material.

Before insertion, a thorough medical assessment is required to ensure suitability. - Contraindications: Active pelvic infection, unexplained vaginal bleeding, or uterine anomalies. - Pregnancy testing: Confirm non‑pregnant status prior to placement. - Follow‑up: Schedule a check‑up 4‑6 weeks after insertion to verify position. - Storage: Store at room temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Levosert’s contraceptive efficacy can be affected by certain medications and conditions.

Major Interactions (Avoid): - Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin) that may reduce levonorgestrel levels. - Certain antiretroviral drugs (e.g., efavirenz) that can decrease contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Antibiotics such as rifampicin that may modestly lower hormone concentrations. - Herbal supplements containing St. John's wort. - Concomitant use of other hormonal contraceptives may increase side‑effect risk.